PickAlpha Evening Insights | 2026-03-23 - Trade Ideas For Tomorrow
• Stocks steady, rates steady as Middle East talks slash crude risk premium. • After hours: Core cut guidance; Gilead deal and NextEra gas-plant land reported. • Tomorrow Trade Ideas
Market Wrap
Market Recap — A midday pivot on easing U.S.-Iran strike risk sent crude sharply lower and steadied broader markets; oil fell from the morning spike ($CL=F). Positive ENCORE Phase 3b data for ARIKAYCE lifted the small-cap biotech cohort ($INSM). Late in the session Core Laboratories trimmed Q1 guidance, flagging Middle East conflict and delays ($CLB), while after-hours M&A and power-project headlines landed for Gilead and NextEra ($GILD, $NEE).
Intraday — From 08:00–16:00 ET data-driven biotech news led early flow as Insmed’s ENCORE topline beat expectations and raised label-expansion prospects ($INSM), then geopolitical headlines about U.S.-Iran talks and postponed strikes sent Brent and WTI tumbling and removed some near-term risk premium from crude ($CL=F).
After Hours — Between 16:00–20:00 ET Core Laboratories cut Q1 guidance citing the conflict and client delays, pressuring oilfield-services sentiment ($CLB); Gilead agreed to acquire Ouro Medicines in a deal up to $2.18bn, reshaping large-cap biotech M&A optics ($GILD); NextEra secured Texas land for a 5GW+ gas plant tied to a U.S.-Japan data-center buildout, supporting utility capex narratives ($NEE).
Trade Ideas For Tomorrow
1/3 Short $CLB — Tactical (1–5d) • Earnings
Plan: Short CLB at next regular-session open to capture guidance-cut repricing over the next 1–3 sessions.
Core Laboratories cut Q1 2026 guidance after the close, now expecting USD 119–123 mn revenue, much lower operating income and EPS of USD 0.05–0.07, citing Middle East conflict, customer delays and supply-chain disruptions. This directly undermines near-term earnings expectations and margins. Oilfield-services names typically reprice sharply to such negative pre-announcements, creating a tactical short opportunity in CLB.
Risk: Exit if CLB closes above its next-session open on the next two sessions. • Valid until 2026-03-30 close (ET)
Trade credibility: actionability ★★★★☆ | timeliness ★★★★☆ | clarity ★★★★☆
2/3 Long $XHB — Tactical (1–5d) • Macro
Plan: If February new home sales >=700k saar, go long XHB in first session after release for next 1–3 sessions.
The Census Bureau will release February new home sales at 10:00 ET. The payload notes that readings at or above 700k saar would signal firmer new-home demand, supporting homebuilders and housing-sensitive equities. With homebuilder sentiment recently edging up, a strong upside surprise could drive a tactical bid in XHB as investors price better orders and resilience despite mixed cyclicals data.
Risk: Exit if XHB closes below its entry-day close on the next two sessions. • Valid until 2026-03-30 close (ET)
Trade credibility: actionability ★★★☆☆ | timeliness ★★★★☆ | clarity ★★★☆☆
3/3 Long $NEE — Tactical (1–5d) • Other
Plan: Go long NEE at next regular-session open and hold for the next 1–3 sessions.
Reuters reported NextEra secured Texas land for a gas-fired plant expected to exceed 5 GW, tied to a roughly USD 33 bn U.S.-Japan data-center power buildout. This signals a growing, AI-driven need for reliable power and a larger regulated capex pipeline. Over the next few sessions, investors may re-rate NEE toward higher long-term growth and earnings visibility.
Risk: Exit if NEE closes below its next-session open for two consecutive sessions. • Valid until 2026-03-30 close (ET)
Trade credibility: actionability ★★★☆☆ | timeliness ★★★☆☆ | clarity ★★★☆☆